Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2010 - 2026)

Biomarin Pharmaceutical has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.4 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 4.01% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (down 4.01% YoY) and the FY2025 annual result came in at 0.44, up 7.05% from the prior year.
• Asset Utilization Ratio retreated to 0.4 in Q1 2026, from 0.42 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.42 in Q4 2025 and troughed at 0.31 in Q1 2022.
• A 5-year average of 0.37 and a median of 0.36 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio declined 4.38% — and 2024, when it gained 15.92%.
• Tracing BMRN's Asset Utilization Ratio over 5 years: stood at 0.33 in 2022, then climbed by 7.27% to 0.36 in 2023, then advanced by 15.92% to 0.41 in 2024, then rose by 2.71% to 0.42 in 2025, then slipped by 5.42% to 0.4 in 2026.
• Business Quant data shows BMRN's Asset Utilization Ratio at 0.4 in Q1 2026, 0.42 in Q4 2025, and 0.41 in Q3 2025.